Clinical Trial Update: ALA-induced PpIX Fluorescence During Brain Tumor Resection [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating 5-ALA–induced PpIX fluorescence for guiding brain tumor resections. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors

Drugs mentioned

• 5-ALA (5-aminolevulinic acid)

Snippet

Sponsor: David W. Roberts | Conditions: Brain Tumors | Phase 1 | Status: ACTIVE_NOT_RECRUITING